351 filings
8-K
PALI
Palisade Bio Inc
10 May 24
Departure of Directors or Certain Officers
4:52pm
8-K
PALI
Palisade Bio Inc
3 May 24
Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
4:56pm
8-K
PALI
Palisade Bio Inc
10 Apr 24
Other Events
5:29pm
8-K
PALI
Palisade Bio Inc
5 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
PALI
Palisade Bio Inc
27 Mar 24
Results of Operations and Financial Condition
4:45pm
8-K
qszlo0
6 Mar 24
Departure of Directors or Certain Officers
4:35pm
8-K
zfgpnk9 twxg264q
13 Feb 24
Departure of Directors or Certain Officers
4:38pm
8-K
j6qg r4x26b
1 Feb 24
Entry into a Material Definitive Agreement
6:02am
8-K
b951ze
29 Jan 24
Palisade Bio Announces Positive Preclinical Data of Lead Program
8:30am
8-K
fxg ps4njsdaw4
7 Nov 23
Regulation FD Disclosure
9:00am
8-K
vavg601zw544fiqmvjf
20 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
mnadgi398ubhyfow7
11 Sep 23
Entry into a Material Definitive Agreement
5:12pm
8-K
p0oag7 2hpykkb
11 Sep 23
Entry into a Material Definitive Agreement
3:30pm
8-K
69nj mndto
8 Sep 23
Entry into a Material Definitive Agreement
4:54pm
8-K
yjb3jsbpqv
9 Jun 23
Entry into a Material Definitive Agreement
9:38am
8-K
asnfiwyocfn
5 Apr 23
Entry into a Material Definitive Agreement
5:18pm
8-K
rdutmthb51c5
13 Mar 23
Other Events
7:00am
8-K
7fqfqy 2xx8
8 Feb 23
Mr. McRae is an industry veteran with a proven track record of operational, clinical, and strategic business development execution
5:08pm
8-K
5yhufel0f
4 Jan 23
Entry into a Material Definitive Agreement
5:18pm
8-K
tquxj5
16 Dec 22
Other Events
4:51pm